Covid-19 roundup: Chi­na joins vac­cine dis­tri­b­u­tion pro­gram re­ject­ed by Trump; Take­da and CSL-led al­liance be­gins blood plas­ma tri­al 

Chi­na has of­fi­cial­ly joined CO­V­AX, the pro­gram set up by CEPI, the WHO, and Gavi to eq­ui­tably dis­trib­ute vac­cines around the world, which the Trump ad­min­is­tra­tion has re­fused to join.

For­eign Min­istry spokesper­son Hua Chun­y­ing said in a state­ment that Chi­na is pledg­ing to make its vac­cines a “glob­al pub­lic good,” pri­or­i­tiz­ing de­vel­op­ing coun­tries.

“We are tak­ing this con­crete step to en­sure eq­ui­table dis­tri­b­u­tion of vac­cines, es­pe­cial­ly to de­vel­op­ing coun­tries, and hope more ca­pa­ble coun­tries will al­so join and sup­port CO­V­AX. Chi­na will al­so strength­en vac­cine co­op­er­a­tion with rel­e­vant coun­tries through the CO­V­AX net­work,” Chun­y­ing said.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.